
GC11066
Indoximod
Also listed as Indoximod (NLG-8189)
Indoximod (NLG-8189) (1-Methyl-D-tryptophan) is an orally active indoleamine 2,3-dioxygenase (IDO) pathway inhibitor· Indoximod (NLG-8189) acts as a Trp mimetic in regulating mTOR· Indoximod (NLG-8189) is an immunometabolic adjuvant used for the research of cancer
ChemicalCAS110117-83-4MW218.25FormulaC12H14N2O2
- CAS number
- 110117-83-4
- Molecular weight
- 218.25
- Formula
- C12H14N2O2
- Solubility
- ≥ 1·12mg/mL in Water with ultrasonic and warming, <2·18mg/mL in DMSO
- InChIKey
- ZADWXFSZEAPBJS-SNVBAGLBSA-N
- Catalogue number
- GC11066
- Brand
- GLPBIO
Computed properties PubChem CID 405012 · XLogP -1.3 · TPSA 68.3 Ų · H-bond donors 2
- XLogP
- -1.3
- TPSA
- 68.3 Ų
- H-bond donors
- 2
- H-bond acceptors
- 3
- Rotatable bonds
- 3
- Heavy atoms
- 16
SMILES CN1C=C(C2=CC=CC=C21)C[C@H](C(=O)O)N
Computed descriptors from PubChem (CID 405012), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il